Listen to researchers with the EMBODY clinical trial discuss the purpose of this Phase 3 study to evaluate the efficacy and safety of Epratuzumab in people with moderate to severe Systemic Lupus Erythematosus. See who may be eligible and how you can participate.
please rate this, guys. This is important for sufferers of lupus.
beautiijunkii 7 months ago